Harrow (HROW) Stock
Harrow (HROW) closed at $30.12 on Nov 13, 2026; its Tenet Score is 41 of 100 against 409 Healthcare peers.
13 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $30.12
- Nov 13, 2026
- Market cap
- $1.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 25.76 – 54.85
- low → high
- Tenet Score
- 41/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Harrow Inc scores 41/100. Weak. Strongest on growth, value is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Omeros CorporationOMER | 24 | $1.3B |
| Amphastar Pharmaceuticals IncAMPH | 67 | $1.3B |
| Opko Health IncOPK | 49 | $1.2B |
| Cronos Group IncCRON | 66 | $1.2B |
| Vor Biopharma IncVOR | 49 | $1.2B |
| GH Research PLCGHRS | 59 | $1.2B |
| Jade Biosciences IncJBIO | 63 | $1.1B |
| Faeth Therapeutics Inc.FTH | 43 | $1.0B |
| Verastem IncVSTM | 18 | $1.0B |
| Savara IncSVRA | 32 | $1.0B |
Common questions
What sector and industry is Harrow in?
Harrow is in the Healthcare sector and the Drugs industry.
What is Harrow's Tenet Score?
Harrow's Tenet Score is 41 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




